Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) insider Todd Duchene sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $20.95, for a total value of $209,500.00. Following the completion of the transaction, the insider directly owned 1,989,101 shares of the company’s stock, valued at $41,671,665.95. The trade was a 0.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Core Scientific Stock Performance
CORZ opened at $18.12 on Thursday. The company has a market cap of $5.76 billion, a price-to-earnings ratio of -4.10 and a beta of 5.50. Core Scientific, Inc. has a one year low of $12.60 and a one year high of $30.46. The business’s fifty day moving average is $25.22 and its two-hundred day moving average is $20.78.
Core Scientific (NASDAQ:CORZ – Get Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The firm had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. On average, analysts predict that Core Scientific, Inc. will post 0.08 EPS for the current fiscal year.
Institutional Investors Weigh In On Core Scientific
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on CORZ shares. Wolfe Research restated a “buy” rating on shares of Core Scientific in a research report on Wednesday. B. Riley Financial raised their price objective on shares of Core Scientific from $30.00 to $33.00 and gave the stock a “buy” rating in a research note on Wednesday, May 27th. Jefferies Financial Group lifted their price objective on Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Keefe, Bruyette & Woods lowered Core Scientific from an “outperform” rating to a “market perform” rating and set a $25.00 target price on the stock. in a research note on Monday. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $32.00 target price on shares of Core Scientific in a report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.43.
View Our Latest Stock Analysis on CORZ
Core Scientific News Summary
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: AMD partnership strengthens Core Scientific’s AI data-center strategy. AMD agreed to secure up to 2.5 gigawatts of capacity for AI deployments, including approximately 530 megawatts covered by 15-year agreements across five sites. Core Scientific said the initial contracts represent roughly $14 billion in potential base revenue, although the figure depends on successful development and deployment. Reuters AMD infrastructure partnership article
- Positive Sentiment: AI-related colocation growth is rapidly changing the company’s revenue mix. Second-quarter revenue was $164.2 million, ahead of expectations, with colocation revenue rising to $136.7 million from $10.6 million a year earlier. Adjusted EBITDA was reported at $41.1 million, supporting the view that Core Scientific is becoming less dependent on cryptocurrency mining. Core Scientific second-quarter results
- Positive Sentiment: Several analysts remain bullish. Canaccord raised its price target to $36 and maintained a Buy rating. Needham and BTIG also reaffirmed Buy ratings with targets of $29 and $38, respectively. Core Scientific additionally appointed technology executive Mark W. Adams to its seven-member board, adding AI and semiconductor-sector experience. Core Scientific board appointment
- Neutral Sentiment: Trading activity indicates continued speculation. Call-option volume was about 55% above its typical level, reflecting bullish positioning but also elevated risk. The AMD transaction includes warrants for up to 30 million CORZ shares at $23.47, which could help fund expansion but may dilute existing shareholders.
- Negative Sentiment: Reported profitability and execution risks are weighing on sentiment. Core Scientific posted a $3.32-per-share GAAP loss, substantially below consensus, despite strong revenue. The loss was largely attributed to noncash warrant fair-value adjustments, while quarterly capital expenditures reached approximately $797.5 million for site conversions. KBW lowered its rating to Market Perform. Insider Todd Duchene also sold 10,000 shares on July 20 and another 10,000 shares on July 27, though the transactions reduced his stake by only about 1% in total.
About Core Scientific
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
Recommended Stories
- Five stocks we like better than Core Scientific
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
